Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. META
5. MU
6. NVDA
7. BLZE
8. IBM
9. PRIM
10. ACN

Go back to Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity

Alnylam Pharma (ALNY) Tops Q3 EPS by 43c, Misses on Revenue; Offers FY24 Guidance

October 31, 2024 8:05 AM EDT

Alnylam Pharma (NASDAQ: ALNY) reported Q3 EPS of ($0.50), $0.43 better than the analyst estimate of ($0.93). Revenue for the quarter came in at $500.92 million versus the consensus estimate of $532.36 million.

The company reiterated 2024 financial guidance, including combined Net Product revenues of $1,575 million to $1,650 million.... More